Definium Therapeutics, Inc. (DFTX)

CIK 1813814 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Definium Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 8, 20268-K0001193125-26-384403
Sep 4, 202640001193125-26-384042
Sep 3, 20261440001950047-26-009064
Aug 14, 2026SCHEDULE 13G/A0000938206-26-000039
Aug 14, 2026SCHEDULE 13G/A0001831942-26-000034
Aug 12, 202640001193125-26-345837
Aug 12, 202640001193125-26-345835
Aug 12, 20268-K0001104659-26-094528
Aug 12, 202640001193125-26-345839
Aug 12, 202640001193125-26-345836
Aug 12, 202640001193125-26-345838
Aug 6, 202610-Q0001193125-26-338066
Aug 6, 20268-K0001193125-26-338006
Jun 26, 202640001193125-26-285563
Jun 26, 202640001193125-26-285567
Jun 26, 202640001193125-26-285564
Jun 26, 202640001193125-26-285562
Jun 26, 202640001193125-26-285558
Jun 25, 20261440001950047-26-006487
Jun 25, 20261440001950047-26-006493
Jun 25, 20261440001950047-26-006489
Jun 25, 20261440001950047-26-006491
Jun 25, 20261440001950047-26-006492
Jun 24, 2026424B50001104659-26-077349
Jun 24, 20268-K0001104659-26-077354